Quarterly ResultApr 22, 2026, 04:21 PM
Medpace Q1 2026 Revenue Jumps 26.5% to $706.6M, EPS $4.28
AI Summary
Medpace Holdings, Inc. reported strong first-quarter 2026 financial results, with revenue increasing 26.5% to $706.6 million. GAAP net income rose to $123.9 million, or $4.28 per diluted share, compared to $3.67 per diluted share in the prior-year period. EBITDA also saw a significant increase of 25.9% to $149.4 million. The company secured $618.4 million in net new business awards and provided optimistic full-year 2026 guidance, forecasting revenue between $2.755 billion and $2.855 billion.
Key Highlights
- Q1 2026 Revenue: $706.6 million, up 26.5% from prior year.
- Q1 2026 GAAP Net Income: $123.9 million, or $4.28 per diluted share.
- Q1 2026 EBITDA: $149.4 million, an increase of 25.9%.
- Net new business awards: $618.4 million, up 23.7%, with 0.88x book-to-bill.
- Backlog as of March 31, 2026: $2,929.2 million, up 2.9%.